JPH0530805B2 - - Google Patents
Info
- Publication number
- JPH0530805B2 JPH0530805B2 JP56026214A JP2621481A JPH0530805B2 JP H0530805 B2 JPH0530805 B2 JP H0530805B2 JP 56026214 A JP56026214 A JP 56026214A JP 2621481 A JP2621481 A JP 2621481A JP H0530805 B2 JPH0530805 B2 JP H0530805B2
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- water
- soluble
- coating
- solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007787 solid Substances 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000000126 substance Substances 0.000 claims abstract description 23
- 238000000576 coating method Methods 0.000 claims abstract description 20
- 239000011248 coating agent Substances 0.000 claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 17
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 15
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 12
- 239000006185 dispersion Substances 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims description 43
- TYQXKHPOXXXCTP-CSLYCKPJSA-N erythromycin A 2'-propanoate Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)OC(=O)CC)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 TYQXKHPOXXXCTP-CSLYCKPJSA-N 0.000 claims description 33
- 229950001028 erythromycin propionate Drugs 0.000 claims description 33
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 12
- 239000000654 additive Substances 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 239000011347 resin Substances 0.000 claims description 10
- 229920005989 resin Polymers 0.000 claims description 10
- 239000004925 Acrylic resin Substances 0.000 claims description 9
- 229920000178 Acrylic resin Polymers 0.000 claims description 9
- 230000000996 additive effect Effects 0.000 claims description 8
- 229940079593 drug Drugs 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 230000002776 aggregation Effects 0.000 claims description 7
- 239000004014 plasticizer Substances 0.000 claims description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 6
- 238000005054 agglomeration Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 239000003792 electrolyte Substances 0.000 claims description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims description 4
- 230000007935 neutral effect Effects 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 3
- 238000004220 aggregation Methods 0.000 claims description 2
- 229960003276 erythromycin Drugs 0.000 claims description 2
- 239000010419 fine particle Substances 0.000 claims description 2
- 230000015271 coagulation Effects 0.000 claims 1
- 238000005345 coagulation Methods 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- 239000002547 new drug Substances 0.000 claims 1
- 238000013019 agitation Methods 0.000 abstract 2
- 239000002245 particle Substances 0.000 description 16
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 14
- 239000007891 compressed tablet Substances 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- -1 polyoxyethylene Polymers 0.000 description 9
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 8
- 235000019640 taste Nutrition 0.000 description 8
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 7
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 7
- 229920003134 Eudragit® polymer Polymers 0.000 description 6
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 6
- 239000007900 aqueous suspension Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 102220289725 rs778831047 Human genes 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 4
- 239000008120 corn starch Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007903 gelatin capsule Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 235000019359 magnesium stearate Nutrition 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- 229910002016 Aerosil® 200 Inorganic materials 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 230000003254 anti-foaming effect Effects 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000001087 glyceryl triacetate Substances 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 235000020374 simple syrup Nutrition 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 101100270982 Arabidopsis thaliana ASE2 gene Proteins 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229930006677 Erythromycin A Natural products 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102220570135 Histone PARylation factor 1_L30D_mutation Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008135 aqueous vehicle Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- XQTWDDCIUJNLTR-CVHRZJFOSA-N doxycycline monohydrate Chemical compound O.O=C1C2=C(O)C=CC=C2[C@H](C)[C@@H]2C1=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]1[C@H]2O XQTWDDCIUJNLTR-CVHRZJFOSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- HQPMKSGTIOYHJT-UHFFFAOYSA-N ethane-1,2-diol;propane-1,2-diol Chemical compound OCCO.CC(O)CO HQPMKSGTIOYHJT-UHFFFAOYSA-N 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- YLGXILFCIXHCMC-JHGZEJCSSA-N methyl cellulose Chemical compound COC1C(OC)C(OC)C(COC)O[C@H]1O[C@H]1C(OC)C(OC)C(OC)OC1COC YLGXILFCIXHCMC-JHGZEJCSSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
ãçºæã®è©³çŽ°ãªèª¬æã
æ¬çºæã¯ãå»è¬æŽ»æ§æåã§ããããããªãã«ãš
ãªã¹ããã€ã·ã³ã被èŠããæ°èŠæ¹æ³åã³ããã«ã
ãåŸãããè¬å€ã«é¢ããã
ãªã¹ããã€ã·ã³ã被èŠããæ°èŠæ¹æ³åã³ããã«ã
ãåŸãããè¬å€ã«é¢ããã
ç¹ã«åäŸã«å¯Ÿããè¬å€ã®çµå£æäžã¯åé¡ãã²ã
èµ·ãããããã«ããããã®åãåé¡ãå€ãã®æ人
ã«ãèµ·ããåŸããäºå®ãæ人åã³åäŸã¯ããŒã©ã
ã³ã«ãã»ã«ã®åœ¢æ åã¯å§æŸé ã®åœ¢æ ã§æäŸããã
è¬å€ããããšã寞æ³ãå°ãããŠãçäžããããšã
ã§ããæãã¯æåŠãããããšãã°ã·ãããã®ãã
ãªæ¶²ç¶åã¯æžæ¿ç¶ãšããŠæäŸãããæãã¯ãŒã©ã
ã³ã«ãã»ã«è¥ããã¯ç Žç å§æŸé ã®å 容ç©ã液äœäž
ã«åæ£ãããŠåŸãããè¬å€ãåå ¥ããããã®ã¯ã
ã容æã§ããã
èµ·ãããããã«ããããã®åãåé¡ãå€ãã®æ人
ã«ãèµ·ããåŸããäºå®ãæ人åã³åäŸã¯ããŒã©ã
ã³ã«ãã»ã«ã®åœ¢æ åã¯å§æŸé ã®åœ¢æ ã§æäŸããã
è¬å€ããããšã寞æ³ãå°ãããŠãçäžããããšã
ã§ããæãã¯æåŠãããããšãã°ã·ãããã®ãã
ãªæ¶²ç¶åã¯æžæ¿ç¶ãšããŠæäŸãããæãã¯ãŒã©ã
ã³ã«ãã»ã«è¥ããã¯ç Žç å§æŸé ã®å 容ç©ã液äœäž
ã«åæ£ãããŠåŸãããè¬å€ãåå ¥ããããã®ã¯ã
ã容æã§ããã
ããããªãããæãçš®ã®æŽ»æ§æåã¯ãããã®åœ¢
æ ã§æäŸããããšäžå¿«ãªå³ãæããã®ã§ãç ç³ã·
ããããçå³æåã¯éŠå³æã¯ããããç 人ã«åå ¥
ããããã«ã¯ååã§ãªãã
æ ã§æäŸããããšäžå¿«ãªå³ãæããã®ã§ãç ç³ã·
ããããçå³æåã¯éŠå³æã¯ããããç 人ã«åå ¥
ããããã«ã¯ååã§ãªãã
ãããã€ãŠæ¬åºé¡äººã¯ç²æ«å掻æ§åã被èŠãã
極ããŠå€ãã®æ¹æ³ãæ€èšãããããããã·ããã
ã«ã¡ãã«ã»ã«ããŒã¹ãã²ã«åç©è³ªããã¯ãã³åã³
ç ç³ã·ãããã䜿çšããŠåŽé§ããããšã«ããã¿ã³
ãã©äžã§è¢«èŠããããšãè©Šã¿ãããã«ã¿ã€ããŒã¹
ïŒTyloseïŒC30ããããªãŠã ã«ã«ããã·ã¡ãã«ã»
ã«ããŒã¹ãŒã©ãã³åã³ã¢ã©ãã€ãŽã ã䜿çšããã
ã€ã¯ãã«ãã»ã«åã®æè¡ã䞊ã³ã«ã€ãªã³äº€ææš¹è
äžã«åºå®ããæè¡ïŒããšãã°IRP64ã®å称ã§ç¥ã
ããŠããïŒãè©Šéšãããå šãŠãããã®è©Šéšã¯ãå š
äœçã«åã¯éšåçã«å€±æã§ãã€ãã
極ããŠå€ãã®æ¹æ³ãæ€èšãããããããã·ããã
ã«ã¡ãã«ã»ã«ããŒã¹ãã²ã«åç©è³ªããã¯ãã³åã³
ç ç³ã·ãããã䜿çšããŠåŽé§ããããšã«ããã¿ã³
ãã©äžã§è¢«èŠããããšãè©Šã¿ãããã«ã¿ã€ããŒã¹
ïŒTyloseïŒC30ããããªãŠã ã«ã«ããã·ã¡ãã«ã»
ã«ããŒã¹ãŒã©ãã³åã³ã¢ã©ãã€ãŽã ã䜿çšããã
ã€ã¯ãã«ãã»ã«åã®æè¡ã䞊ã³ã«ã€ãªã³äº€ææš¹è
äžã«åºå®ããæè¡ïŒããšãã°IRP64ã®å称ã§ç¥ã
ããŠããïŒãè©Šéšãããå šãŠãããã®è©Šéšã¯ãå š
äœçã«åã¯éšåçã«å€±æã§ãã€ãã
ããšãã°ãŠãŒãã©ã®ããåã®ã¢ã¯ãªã«æš¹èã®ã
ããªæãçš®ã®ãã©ã¹ããã¯ã¯ã被èŠãã€ã«ã ã圢
æãããããã®èœåã«ã€ããŠç¥ãããŠããããã
ãæš¹èã®å¹Ÿã€ãã¯æ°Žæ§æžæ¿ç©ãšããŠååšãã被èŠ
ãã€ã«ã ã¯ãã®æžæ¿ç©ããã®æ°Žã®èžçºã«ãã圢æ
ããããæ¬åºé¡äººã¯ãããšãã°ããŒã ã»ãã¢ã«ã
瀟ïŒãã€ãé£éŠå ±ååœïŒã«ãããŠãŒãã©ã®ãã
E30Dåã³L30Dã®å称ã§è²©å£²ãããŠãããããªã
ã®çš®ã®æ°Žæ§æžæ¿ç©ã䜿çšããŠåŽé§ã«ãã被èŠã圢
æãããããšãè©Šã¿ãããã®æè¡ã¯ãæš¹èã®æã¯
貯èµéšäžã«ååºããã掻æ§æåã®æžæ¿ç©ã«ã¯äœ¿çš
ã§ãããåŽé§åšãéå¡ãããã
ããªæãçš®ã®ãã©ã¹ããã¯ã¯ã被èŠãã€ã«ã ã圢
æãããããã®èœåã«ã€ããŠç¥ãããŠããããã
ãæš¹èã®å¹Ÿã€ãã¯æ°Žæ§æžæ¿ç©ãšããŠååšãã被èŠ
ãã€ã«ã ã¯ãã®æžæ¿ç©ããã®æ°Žã®èžçºã«ãã圢æ
ããããæ¬åºé¡äººã¯ãããšãã°ããŒã ã»ãã¢ã«ã
瀟ïŒãã€ãé£éŠå ±ååœïŒã«ãããŠãŒãã©ã®ãã
E30Dåã³L30Dã®å称ã§è²©å£²ãããŠãããããªã
ã®çš®ã®æ°Žæ§æžæ¿ç©ã䜿çšããŠåŽé§ã«ãã被èŠã圢
æãããããšãè©Šã¿ãããã®æè¡ã¯ãæš¹èã®æã¯
貯èµéšäžã«ååºããã掻æ§æåã®æžæ¿ç©ã«ã¯äœ¿çš
ã§ãããåŽé§åšãéå¡ãããã
ãã®åŸè
ã®ç 究ãè¡ãªã€ãŠããéãæ¬åºé¡äºº
ã¯ã被èŠãåºäœçæ°Žæ§ç©è³ªã®æ°Žæ§æžæ¿ç©ããæ°Žã
èžçºãããŠåœ¢æãããã®ã§ãªããæžæ¿ç©äžã§ã®å
éã«ãã圢æããããšãããå»è¬æŽ»æ§æåã被èŠ
ããæ°èŠãªæ¹æ³ãèŠåºããããã€ã«ã ã®åãå¢å
ã®åœæ°ãšããŠã掻æ§æåã®å³ãå ãæåã«æå¹ã«
é èœããã次ãã§ããã«æŽ»æ§æåã®é 延æŸåºã®å¹
æãåŸãããã
ã¯ã被èŠãåºäœçæ°Žæ§ç©è³ªã®æ°Žæ§æžæ¿ç©ããæ°Žã
èžçºãããŠåœ¢æãããã®ã§ãªããæžæ¿ç©äžã§ã®å
éã«ãã圢æããããšãããå»è¬æŽ»æ§æåã被èŠ
ããæ°èŠãªæ¹æ³ãèŠåºããããã€ã«ã ã®åãå¢å
ã®åœæ°ãšããŠã掻æ§æåã®å³ãå ãæåã«æå¹ã«
é èœããã次ãã§ããã«æŽ»æ§æåã®é 延æŸåºã®å¹
æãåŸãããã
ãããã€ãŠãæ¬çºæã®äž»é¡ã¯ã倧ããŠæ°Žæº¶æ§ã§
ãªã埮ç²å圢æ ã®åºäœç¶å»è¬æŽ»æ§æåã§ãããã
ããªãã«ãšãªã¹ããã€ã·ã³ã被èŠããæ°èŠæ¹æ³ã§
ããããã®æ¹æ³ã¯åèšããããªãã«ãšãªã¹ããã€
ã·ã³ãšå»è¬äžèš±å®¹ãããåºäœæ°Žæ§ç©è³ªã§ããã¢ã¯
ãªã«æš¹èã®æ°Žæ§åæ£ç©ãšãæªæäžã«æ··åããå°ãª
ããšãäžçš®ã®ç©ççè¥ããã¯ååŠçæ段åã¯ãã
ãã®æ段ã®çµåããçšããŠåèšçæ°Žæ§ç©è³ªãåé
ããããã®ããã«ããŠè¢«èŠãããããããªãã«ãš
ãªã¹ããã€ã·ã³ãåé¢ããŠä¹Ÿç¥ãããããšãç¹åŸŽ
ãšããã
ãªã埮ç²å圢æ ã®åºäœç¶å»è¬æŽ»æ§æåã§ãããã
ããªãã«ãšãªã¹ããã€ã·ã³ã被èŠããæ°èŠæ¹æ³ã§
ããããã®æ¹æ³ã¯åèšããããªãã«ãšãªã¹ããã€
ã·ã³ãšå»è¬äžèš±å®¹ãããåºäœæ°Žæ§ç©è³ªã§ããã¢ã¯
ãªã«æš¹èã®æ°Žæ§åæ£ç©ãšãæªæäžã«æ··åããå°ãª
ããšãäžçš®ã®ç©ççè¥ããã¯ååŠçæ段åã¯ãã
ãã®æ段ã®çµåããçšããŠåèšçæ°Žæ§ç©è³ªãåé
ããããã®ããã«ããŠè¢«èŠãããããããªãã«ãš
ãªã¹ããã€ã·ã³ãåé¢ããŠä¹Ÿç¥ãããããšãç¹åŸŽ
ãšããã
ãã®æ¹æ³ã¯ãåé¢ãã掻æ§æååã¯è€æ°æŽ»æ§æ
åã®çžæº¶æ§æ··åç©ã«å¿çšããããšãã§ããã掻æ§
æåã¯ãäžèšã«ç€ºããã€ä»¥äžã«èšèŒããåºæºãæº
足ãããã°ãªããªãã
åã®çžæº¶æ§æ··åç©ã«å¿çšããããšãã§ããã掻æ§
æåã¯ãäžèšã«ç€ºããã€ä»¥äžã«èšèŒããåºæºãæº
足ãããã°ãªããªãã
倧ããŠæ°Žæº¶æ§ã§ãªãåºäœç¶å»è¬æŽ»æ§æåãšã¯ã
20âã®100容ééšä»¥äžã®æ°Žã«ïŒéééšã溶解ãã
ãå»è¬æŽ»æ§æåãšç解ãããã
20âã®100容ééšä»¥äžã®æ°Žã«ïŒéééšã溶解ãã
ãå»è¬æŽ»æ§æåãšç解ãããã
掻æ§æåã®ç²å寞æ³ã¯ããšãã°ïŒã500ÎŒã®ç¯
å²ãšããããšãã§ããç²åã¯ããšãã°éç¶åã¯ã¿
ãã¬ãã圢ç¶ãšããããšãã§ãããè€æ°ã®æŽ»æ§æ
åãçµåããå Žåããããã®ç²åºŠã¯åãçšåºŠã®å€§
ããã§ããã®ã奜ãŸããã
å²ãšããããšãã§ããç²åã¯ããšãã°éç¶åã¯ã¿
ãã¬ãã圢ç¶ãšããããšãã§ãããè€æ°ã®æŽ»æ§æ
åãçµåããå Žåããããã®ç²åºŠã¯åãçšåºŠã®å€§
ããã§ããã®ã奜ãŸããã
æ¬çºæã«ããæ°Žæ§æžæ¿ç©äžã®åºäœçæ°Žæ§ç©è³ª
ã¯ãããšãã°å ç±ãå·åŽãé»æ°å解äœçšåã¯PHå€
åã®ãããªæãçš®ã®ç©ççè¥ããã¯ååŠçæ¡ä»¶ã®
äžã§åéãããããšãã§ããå»è¬äžèš±å®¹ãããã
ã®ã§ãªããã°ãªããªãã
ã¯ãããšãã°å ç±ãå·åŽãé»æ°å解äœçšåã¯PHå€
åã®ãããªæãçš®ã®ç©ççè¥ããã¯ååŠçæ¡ä»¶ã®
äžã§åéãããããšãã§ããå»è¬äžèš±å®¹ãããã
ã®ã§ãªããã°ãªããªãã
ç¹ã«å¡æå·¥æ¥ã«ãããŠããã©ã¹ããã¯ææã®æ°Ž
æ§åæ£ç©äžŠã³ã«ãã®è£œé æ¹æ³ã¯åšç¥ãããŠããã
ãããã¯ã倧æµã®å ŽåçŽåŸ10-2ã1ÎŒã®çç¶ã§ãã
è¶ é¡åŸ®é¡ç²åã®æ¥µããŠåŸ®çŽ°ãªå®å®æžæ¿ç©ã§ãã€
ãŠãéåã«ããä¹³åã®æ¹æ³ã«ããåŸãããããã
ãæžæ¿ç©ã®æããã®ã¯ç¹ã«å»è¬åå·¥æ¥ã«å¯ŸããŠé
çºããããããã¯ããšãã°ã¡ã¿ã¯ãªã«é žåã³ã¢ã¯
ãªã«é žãšã¹ãã«ã®éåç©ã®æ°Žæ§æžæ¿ç©ã§ãã€ãŠã
ãŠãŒãã©ã®ããE30Dã®å称ã§è²©å£²ãããŠããã
ã®ãæããã¯ã¡ã¿ã¯ãªã«é žã«åºã¥ãé ã€ãªã³æ§é
åç©ã®æ°Žæ§æžæ¿ç©ã§ãã€ãŠãããŒã ãã¢ã«ã瀟
ïŒãã«ã ã¹ã¿ããâãã€ãé£éŠå ±ååœïŒã«ãããŠ
ãŒãã©ã®ããL30Dã®å称ã§è²©å£²ãããŠãããã®
ã§ããã
æ§åæ£ç©äžŠã³ã«ãã®è£œé æ¹æ³ã¯åšç¥ãããŠããã
ãããã¯ã倧æµã®å ŽåçŽåŸ10-2ã1ÎŒã®çç¶ã§ãã
è¶ é¡åŸ®é¡ç²åã®æ¥µããŠåŸ®çŽ°ãªå®å®æžæ¿ç©ã§ãã€
ãŠãéåã«ããä¹³åã®æ¹æ³ã«ããåŸãããããã
ãæžæ¿ç©ã®æããã®ã¯ç¹ã«å»è¬åå·¥æ¥ã«å¯ŸããŠé
çºããããããã¯ããšãã°ã¡ã¿ã¯ãªã«é žåã³ã¢ã¯
ãªã«é žãšã¹ãã«ã®éåç©ã®æ°Žæ§æžæ¿ç©ã§ãã€ãŠã
ãŠãŒãã©ã®ããE30Dã®å称ã§è²©å£²ãããŠããã
ã®ãæããã¯ã¡ã¿ã¯ãªã«é žã«åºã¥ãé ã€ãªã³æ§é
åç©ã®æ°Žæ§æžæ¿ç©ã§ãã€ãŠãããŒã ãã¢ã«ã瀟
ïŒãã«ã ã¹ã¿ããâãã€ãé£éŠå ±ååœïŒã«ãããŠ
ãŒãã©ã®ããL30Dã®å称ã§è²©å£²ãããŠãããã®
ã§ããã
åéã®éãæš¹èã®ç²åã¯æ¹æã«ããæžæ¿ç©äžã«
ä¿ããã掻æ§æåã®åºäœç²åã®åšãã«éåããŠã
ãã被èŠããã
ä¿ããã掻æ§æåã®åºäœç²åã®åšãã«éåããŠã
ãã被èŠããã
åºäœçæ°Žæ§ç©è³ªã®æ°Žæ§åæ£ç©ã¯ãããšãã°é»è§£
質ãPHå€åãå ç±åã¯å·åŽã®ãããªæãçš®ã®èŠå
ã«å¯Ÿãéæã§ããããããèŠå ã¯ç²åãäºãã«è
åãããããšã«ããæžæ¿ç©äžã§åèšç©è³ªã®åéã
ã²ãèµ·ããããšãã§ããã
質ãPHå€åãå ç±åã¯å·åŽã®ãããªæãçš®ã®èŠå
ã«å¯Ÿãéæã§ããããããèŠå ã¯ç²åãäºãã«è
åãããããšã«ããæžæ¿ç©äžã§åèšç©è³ªã®åéã
ã²ãèµ·ããããšãã§ããã
ãã被èŠããã掻æ§æåã¯ãããšãã°ãã«ã³ã
æ³åã¯é å¿åé¢ã«ããã奜ãŸããã¯éã«ããæ¯
液ããåé¢ããããšãã§ãããéã¯ããããŒ
æã«ãã€ãŠè¡ãªãã®ãæå©ã§ãããæžå§åã¯å å§
ã«ããä¿é²ãããããšãã§ãããéåšäžã«ä¿æ
ãããåºäœããã®ãŸãŸä¹Ÿç¥ããããšãã§ããæã
ã¯ææã«å¿ãæåã«ããšãã°çŽæ°Žã«ããæŽæµãã
ããšãã§ããã也ç¥ã¯ãããšãã°æŽ»æ§æååã³åº
äœçæ°Žæ§ç©è³ªã«å¯ŸããŠé©ããå ç±ãçšããŠåã¯çš
ããã«ææ°ãªãŒãã³å ã§ä¹Ÿç¥ãããŠãæšæºæ³ã«ã
ãè¡ãªãããšãã§ããã
æ³åã¯é å¿åé¢ã«ããã奜ãŸããã¯éã«ããæ¯
液ããåé¢ããããšãã§ãããéã¯ããããŒ
æã«ãã€ãŠè¡ãªãã®ãæå©ã§ãããæžå§åã¯å å§
ã«ããä¿é²ãããããšãã§ãããéåšäžã«ä¿æ
ãããåºäœããã®ãŸãŸä¹Ÿç¥ããããšãã§ããæã
ã¯ææã«å¿ãæåã«ããšãã°çŽæ°Žã«ããæŽæµãã
ããšãã§ããã也ç¥ã¯ãããšãã°æŽ»æ§æååã³åº
äœçæ°Žæ§ç©è³ªã«å¯ŸããŠé©ããå ç±ãçšããŠåã¯çš
ããã«ææ°ãªãŒãã³å ã§ä¹Ÿç¥ãããŠãæšæºæ³ã«ã
ãè¡ãªãããšãã§ããã
次ãã§ã也ç¥ãã被èŠæŽ»æ§æåããããšãã°ç²
床èšã«ãã枬å®ãããããŠããšãã°å§æŸé ããŒã©
ãã³ã«ãã»ã«ãã·ãããåã¯æžæ¿ç©åœ¢æ ã®ãããª
çµå£æäžçšã®æšæºçå»è¬è£œé ã«å¯Ÿããæªè¢«èŠã®äž
è¬ç掻æ§æåãšåæ§ã«äœ¿çšãããããçæ°Žæ§ç©è³ª
ã®æº¶å€ã®äœ¿çšã¯åé¿ããã
床èšã«ãã枬å®ãããããŠããšãã°å§æŸé ããŒã©
ãã³ã«ãã»ã«ãã·ãããåã¯æžæ¿ç©åœ¢æ ã®ãããª
çµå£æäžçšã®æšæºçå»è¬è£œé ã«å¯Ÿããæªè¢«èŠã®äž
è¬ç掻æ§æåãšåæ§ã«äœ¿çšãããããçæ°Žæ§ç©è³ª
ã®æº¶å€ã®äœ¿çšã¯åé¿ããã
äžèšæ¹æ³ãè¡ãªãããã®å¥œé©æ¡ä»¶äžã«ãããŠã
䜿çšããåéã®ç©ççæ段ã¯æž©åºŠã®å€åã§ããã
䜿çšããåéã®ååŠçæ段ã¯é»è§£è³ªã奜ãŸããã¯
å¡©åãããªãŠã ã§ãããå ç±åã³é»è§£è³ªã®äœ¿çšã
çµåããã®ã極ããŠæå©ã§ããã
䜿çšããåéã®ç©ççæ段ã¯æž©åºŠã®å€åã§ããã
䜿çšããåéã®ååŠçæ段ã¯é»è§£è³ªã奜ãŸããã¯
å¡©åãããªãŠã ã§ãããå ç±åã³é»è§£è³ªã®äœ¿çšã
çµåããã®ã極ããŠæå©ã§ããã
掻æ§æåã湿最ãããã«ã¯åºäœçæ°Žæ§ç©è³ªãšæŽ»
æ§æåãšã®æ··åç©ã«æ¹¿æœ€å€ãå ããã®ãç¹ã«æå©
ã§ãããããšãã°ãè¡šé¢æŽ»æ§å€ãããšãã°0.2ã
ïŒïŒ ã®å²åã§äœ¿çšãããããããŠãæ··åäžéã«ã
ãã掻æ§æåã®ããè¯å¥œãªæžæ¿ç©ãåŸããããç¹
ã«ããŠãŒãžã³ã»ã¯ãŒã«ãã³ç€Ÿã«ãããã«ãããã¯
F68ã®å称ã§è²©å£²ãããŠãã補åãèããããã
æ§æåãšã®æ··åç©ã«æ¹¿æœ€å€ãå ããã®ãç¹ã«æå©
ã§ãããããšãã°ãè¡šé¢æŽ»æ§å€ãããšãã°0.2ã
ïŒïŒ ã®å²åã§äœ¿çšãããããããŠãæ··åäžéã«ã
ãã掻æ§æåã®ããè¯å¥œãªæžæ¿ç©ãåŸããããç¹
ã«ããŠãŒãžã³ã»ã¯ãŒã«ãã³ç€Ÿã«ãããã«ãããã¯
F68ã®å称ã§è²©å£²ãããŠãã補åãèããããã
埮现ãã€åºäœã®è¢«èŠãã€ã«ã ãåŸãŠæŽ»æ§æåã®
ç²åã®é ã ãŸãååã«è¢«èŠããããã«ã¯ãæ··åç©
äžã«ããšãã°ããªãªãã·ãšãã¬ã³ã°ãªã³ãŒã«4000
è¥ããã¯6000ã奜ãŸããã¯åŸè ã®ãããªå¯å¡å€ã
é åããããšãç¹ã«æšå¥šããããããšãã°ããªã¢
ã»ãã³ã®ãããªä»ã®æ°Žæº¶æ§åã¯åæ£æ§å¯å¡å€ã䜿
çšããããšãã§ãããã氎溶æ§å¯å¡å€ãæ··åç©ã®
çŽ0.2ãïŒééïŒ ã®å²åã§äœ¿çšããã®ã奜ãŸããã
ç²åã®é ã ãŸãååã«è¢«èŠããããã«ã¯ãæ··åç©
äžã«ããšãã°ããªãªãã·ãšãã¬ã³ã°ãªã³ãŒã«4000
è¥ããã¯6000ã奜ãŸããã¯åŸè ã®ãããªå¯å¡å€ã
é åããããšãç¹ã«æšå¥šããããããšãã°ããªã¢
ã»ãã³ã®ãããªä»ã®æ°Žæº¶æ§åã¯åæ£æ§å¯å¡å€ã䜿
çšããããšãã§ãããã氎溶æ§å¯å¡å€ãæ··åç©ã®
çŽ0.2ãïŒééïŒ ã®å²åã§äœ¿çšããã®ã奜ãŸããã
æ··åç©ã«å¯Ÿãæ¶æ³¡å€ãããšãã°æ¶æ³¡æ§ã·ãªã³ãŒ
ã³30ãob1Nã®å称ã§ç¥ãããæ¶æ³¡çšã·ãªã³ãŒã³
ãããšãã°0.01ïŒ ã®å²åã§æ·»å ããããšã奜ãŸã
ããããããªãããããšãã°ã·ãªã³ãŒã³ASE2ã
䜿çšããããšãã§ããã
ã³30ãob1Nã®å称ã§ç¥ãããæ¶æ³¡çšã·ãªã³ãŒã³
ãããšãã°0.01ïŒ ã®å²åã§æ·»å ããããšã奜ãŸã
ããããããªãããããšãã°ã·ãªã³ãŒã³ASE2ã
䜿çšããããšãã§ããã
被èŠãã¹ã掻æ§æåã®ç²åã®ééã«å¯Ÿããåºäœ
çæ°Žæ§ç©è³ªã®äœ¿çšéã¯å€§ããå€åãããããšãã§
ããåéã®å Žå埮ç²åçç£ç©ã¯åäžå¡ç¶äœã®åã
çç£ç©ããããã€ãšå€§ããæ¯è¡šé¢ç©ãæãããã
ãã€ãŠåã被èŠåããããªãã¡åãå¹æãåŸãã«
ã¯ãã€ãšå€éã®åèšç©è³ªãå¿ èŠãšããã§ãããã
åºäœçæ°Žæ§ç©è³ªã®äœ¿çšéã®æ£ç¢ºãªæž¬å®ã¯ãåœæ¥è
ã®æè¡ç¯å²å ã§ãããçŽåŸ3ÎŒãã€å¹³åé·ã15ÎŒã®
éç¶ã®çµæ¶ã«å¯ŸããŠã¯åºäœçæ°Žæ§è¢«èŠç©è³ªã¯ããš
ãã°è¢«èŠç²åã®ééã®ïŒã60ïŒ ãšããããšãã§
ããããšãã°ïŒãïŒïŒ ã®å°å²åã¯å³ãå¹æçã«é
èœãããç²åã«çžåœããåºäœçæ°Žæ§ç©è³ªã®æ¯çã
é«ããããšã«ããé 延æŸåºã®å¹æãä»å ãããã
ããšãã°èçŒã§èŠãããããªãã€ãšå€§ããªç²åã®
å Žåã被èŠç²åã®ééã«å¯Ÿããåºäœçæ°Žæ§ç©è³ªã®
æ¯çã¯ãããããã€ãšå°ããããšã¯å¿è«ã§ããã
çæ°Žæ§ç©è³ªã®äœ¿çšéã¯å€§ããå€åãããããšãã§
ããåéã®å Žå埮ç²åçç£ç©ã¯åäžå¡ç¶äœã®åã
çç£ç©ããããã€ãšå€§ããæ¯è¡šé¢ç©ãæãããã
ãã€ãŠåã被èŠåããããªãã¡åãå¹æãåŸãã«
ã¯ãã€ãšå€éã®åèšç©è³ªãå¿ èŠãšããã§ãããã
åºäœçæ°Žæ§ç©è³ªã®äœ¿çšéã®æ£ç¢ºãªæž¬å®ã¯ãåœæ¥è
ã®æè¡ç¯å²å ã§ãããçŽåŸ3ÎŒãã€å¹³åé·ã15ÎŒã®
éç¶ã®çµæ¶ã«å¯ŸããŠã¯åºäœçæ°Žæ§è¢«èŠç©è³ªã¯ããš
ãã°è¢«èŠç²åã®ééã®ïŒã60ïŒ ãšããããšãã§
ããããšãã°ïŒãïŒïŒ ã®å°å²åã¯å³ãå¹æçã«é
èœãããç²åã«çžåœããåºäœçæ°Žæ§ç©è³ªã®æ¯çã
é«ããããšã«ããé 延æŸåºã®å¹æãä»å ãããã
ããšãã°èçŒã§èŠãããããªãã€ãšå€§ããªç²åã®
å Žåã被èŠç²åã®ééã«å¯Ÿããåºäœçæ°Žæ§ç©è³ªã®
æ¯çã¯ãããããã€ãšå°ããããšã¯å¿è«ã§ããã
æ¬çºæã®ä»ã®é¢ã«ããã°ãæ··åç©äžã«ããã«æ°Ž
溶æ§åã¯èŠªæ°Žæ§ã®æ·»å ç©ãå ããããã次ãã§å³
ã®é èœãããè¬å€ãåŸããããã®æŽ»æ§æåã¯èã®
段éã§æ¥éã«æŸåºãããããã®æ¥éæŸåºã¯ãåžå
ãæ¶å管ã®äžéšã§è¡ãªãããããããªãã«ãšãªã¹
ããã€ã·ã³åã¯ããã·ãµã€ã¯ãªã³ã®ãããªæçç©
質ã®å Žåã®ç¹ã«èŠæ±ãããã
溶æ§åã¯èŠªæ°Žæ§ã®æ·»å ç©ãå ããããã次ãã§å³
ã®é èœãããè¬å€ãåŸããããã®æŽ»æ§æåã¯èã®
段éã§æ¥éã«æŸåºãããããã®æ¥éæŸåºã¯ãåžå
ãæ¶å管ã®äžéšã§è¡ãªãããããããªãã«ãšãªã¹
ããã€ã·ã³åã¯ããã·ãµã€ã¯ãªã³ã®ãããªæçç©
質ã®å Žåã®ç¹ã«èŠæ±ãããã
äžèšæ¹æ³ãå®æœãã奜é©æ¡ä»¶äžã«ãããŠãæ··å
ç©ã¯ããããªãã«ãšãªã¹ããã€ã·ã³ã§ãã掻æ§æ
åçŽïŒã60éšãã¢ã¯ãªã«æš¹èïŒéšã«å¯ŸããŠå«æã
ããããããªãã«ãšãªã¹ããã€ã·ã³ã«ã€ããŠã¯ã
ã¹ãããšã³ã¹åã³ã³ãã³ã«ããèšèŒãããŠãã
ïŒã¢ã³ãããªããã¯ã»ã¢ãã¬ãŒã³ã1958ã59ã第
346é ïŒã
ç©ã¯ããããªãã«ãšãªã¹ããã€ã·ã³ã§ãã掻æ§æ
åçŽïŒã60éšãã¢ã¯ãªã«æš¹èïŒéšã«å¯ŸããŠå«æã
ããããããªãã«ãšãªã¹ããã€ã·ã³ã«ã€ããŠã¯ã
ã¹ãããšã³ã¹åã³ã³ãã³ã«ããèšèŒãããŠãã
ïŒã¢ã³ãããªããã¯ã»ã¢ãã¬ãŒã³ã1958ã59ã第
346é ïŒã
åŸè
ã®æ¹æ³ãè¡ãªãç¹å®æ¹æ³ã«ãããŠãæ··åç©
ã¯çŽïŒã15éšã®ããããªãã«ãšãªã¹ããã€ã·ã³ãš
ïŒã15éšã®æ°Žæº¶æ§è¥ããã¯èŠªæ°Žæ§æ·»å ç©ïŒããã¯
éçé žãããªãŠã ã§ããïŒãšããïŒéšã®äžèšåŒã®
äžæ§ã¢ã¯ãªã«æš¹èïŒ ãåŒäžãã¯æ°ŽçŽ åååã¯ã¡ãã«åºã瀺ãã
Râ²ã¯ã¡ãã«èããã¯ãšãã«åºã瀺ããïœã¯ãã®
æš¹èãçŽ200000ã600000ã®ååéãæãããããª
æ°ã§ããã ã«å¯ŸããŠå«æããã
ã¯çŽïŒã15éšã®ããããªãã«ãšãªã¹ããã€ã·ã³ãš
ïŒã15éšã®æ°Žæº¶æ§è¥ããã¯èŠªæ°Žæ§æ·»å ç©ïŒããã¯
éçé žãããªãŠã ã§ããïŒãšããïŒéšã®äžèšåŒã®
äžæ§ã¢ã¯ãªã«æš¹èïŒ ãåŒäžãã¯æ°ŽçŽ åååã¯ã¡ãã«åºã瀺ãã
Râ²ã¯ã¡ãã«èããã¯ãšãã«åºã瀺ããïœã¯ãã®
æš¹èãçŽ200000ã600000ã®ååéãæãããããª
æ°ã§ããã ã«å¯ŸããŠå«æããã
ããã«ãæ¬çºæã®äž»é¡ã¯ã倧ããŠæ°Žæº¶æ§ã§ãªã
埮ç²å圢æ ã®åºäœç¶å»è¬æŽ»æ§æåã§ããããããª
ãã«ãšãªã¹ããã€ã·ã³ã«ããæ§æãããåèšæŽ»æ§
æåãå»è¬äžèš±å®¹ãããåºäœçæ°Žæ§ç©è³ªã§ããã¢
ã¯ãªã«æš¹èã®æ°Žæ§åæ£ç©ã®åéã«ãã圢æããã
被èŠã«ããèŠãããŠããããšãç¹åŸŽãšããæ°èŠãª
è¬å€ã«ããã
埮ç²å圢æ ã®åºäœç¶å»è¬æŽ»æ§æåã§ããããããª
ãã«ãšãªã¹ããã€ã·ã³ã«ããæ§æãããåèšæŽ»æ§
æåãå»è¬äžèš±å®¹ãããåºäœçæ°Žæ§ç©è³ªã§ããã¢
ã¯ãªã«æš¹èã®æ°Žæ§åæ£ç©ã®åéã«ãã圢æããã
被èŠã«ããèŠãããŠããããšãç¹åŸŽãšããæ°èŠãª
è¬å€ã«ããã
æ¬çºæã®äž»é¡ãæ§æããè¬å€ã®ãã¡ãç¹ã«ãåº
äœçæ°Žæ§ç©è³ªãäžèšã®äžæ§ã¢ã¯ãªã«æš¹èã§ããã
ãšãç¹åŸŽãšãããã®ããããããã
äœçæ°Žæ§ç©è³ªãäžèšã®äžæ§ã¢ã¯ãªã«æš¹èã§ããã
ãšãç¹åŸŽãšãããã®ããããããã
ãåŒäžãã¯æ°ŽçŽ åååã¯ã¡ãã«åºã瀺ãã
Râ²ã¯ã¡ãã«è¥ããã¯ãšãã«åºã瀺ããïœã¯åèš
æš¹èãçŽ200000ã600000ã®ååéãæãããããª
æ°ã§ãããã
Râ²ã¯ã¡ãã«è¥ããã¯ãšãã«åºã瀺ããïœã¯åèš
æš¹èãçŽ200000ã600000ã®ååéãæãããããª
æ°ã§ãããã
ãã®æš¹èã¯å¥œãŸããã¯ãŠãŒãã©ã®ããE30Dã®
å称ã§è²©å£²ãããŠããæ°Žæ§åæ£ç©ããçãããã®
ã§ããã
å称ã§è²©å£²ãããŠããæ°Žæ§åæ£ç©ããçãããã®
ã§ããã
ãã®çš®ã®è¬å€ã«ãããŠã掻æ§æåã®å³ã¯é èœã
ãã掻æ§æåã®æŸåºã¯ææã«å¿ãæ°æéã«ããã€
ãŠåŒã延ã°ãããšãã§ããã
ãã掻æ§æåã®æŸåºã¯ææã«å¿ãæ°æéã«ããã€
ãŠåŒã延ã°ãããšãã§ããã
æ¬çºæã®äž»é¡ãæ§æããè¬å€ã®ãã¡ã被èŠãå°
ãªããšãäžçš®ã®æ°Žæº¶æ§è¥ããã¯èŠªæ°Žæ§æ·»å ç©ãã
ãã«å«æããããšãç¹åŸŽãšãããã®ãèããã
ãã氎溶æ§è¥ããã¯èŠªæ°Žæ§ã®æ·»å ç©ã¯ãããšãã°
ä¹³ç³ãèç³ãããªããã«ãããªãã³ãå¡©åãããª
ãŠã åã¯éçé žãããªãŠã ã®ãããªç©è³ªãšããã
ãšãã§ããããããã¯ã也ç¥ç©è³ªãšããŠè¡šãããŠ
åèšåºäœçæ°Žæ§ç©è³ªã®çŽ20åãŸã§ã®ç¯å²ã®æ¯çã§
å ããããšãã§ããã
ãªããšãäžçš®ã®æ°Žæº¶æ§è¥ããã¯èŠªæ°Žæ§æ·»å ç©ãã
ãã«å«æããããšãç¹åŸŽãšãããã®ãèããã
ãã氎溶æ§è¥ããã¯èŠªæ°Žæ§ã®æ·»å ç©ã¯ãããšãã°
ä¹³ç³ãèç³ãããªããã«ãããªãã³ãå¡©åãããª
ãŠã åã¯éçé žãããªãŠã ã®ãããªç©è³ªãšããã
ãšãã§ããããããã¯ã也ç¥ç©è³ªãšããŠè¡šãããŠ
åèšåºäœçæ°Žæ§ç©è³ªã®çŽ20åãŸã§ã®ç¯å²ã®æ¯çã§
å ããããšãã§ããã
ãã®è¬å€ã«ãããŠã掻æ§æåã®å³ãé èœããã
掻æ§æåãèã«ãããŠæŸåºãããæ·»å ç©ã®å²åã
å€ãçšãæåã®æŸåºãããæ¥éãšãªãã
掻æ§æåãèã«ãããŠæŸåºãããæ·»å ç©ã®å²åã
å€ãçšãæåã®æŸåºãããæ¥éãšãªãã
ãããè¬å€ã®ãã¡ã奜ãŸããã¯ã氎溶æ§è¥ãã
ã¯èŠªæ°Žæ§æ·»å ç©ãéçé žãããªãŠã åã³å¡©åãã
ãªãŠã ãããªã矀ããéžæããããšãç¹åŸŽãšãã
ãã®ããããããã
ã¯èŠªæ°Žæ§æ·»å ç©ãéçé žãããªãŠã åã³å¡©åãã
ãªãŠã ãããªã矀ããéžæããããšãç¹åŸŽãšãã
ãã®ããããããã
æ¬çºæã«ããç¹ã«å¥œé©ãªè¬å€ã¯ã被èŠãããã«
å¯å¡å€ãå«æããããšãç¹åŸŽãšãããã®ã§ããã
å®éäžã被èŠãã¹ã掻æ§æåã®ç²åã¯æ¥µããŠäžèŠ
åãªåœ¢ç¶ãæããå¯å¡å€ã®æ·»å ã«ãã埮现ãã€åº
äœã®è¢«èŠãã€ã«ã ãåŸãããšãã§ããããã¯æŽ»æ§
æåã®ç²åã®é ã ã«ååã«ä»çãããããšãã°ã
ãªã¢ã»ãã³åã¯ããªãªãã·ãšãã¬ã³ã°ãªã³ãŒã«
4000è¥ããã¯6000ã䜿çšããããšãã§ãããããš
ãã°ããªãªãã·ãšãã¬ã³ã°ã«ã³ãŒã«6000ã®ãããª
氎溶æ§å¯å¡å€ãæ··åç©ã«å¯ŸãçŽ0.2ãïŒééïŒ ã®
å²åã§äœ¿çšããã®ãç¹ã«å¥œé©ã§ããã
å¯å¡å€ãå«æããããšãç¹åŸŽãšãããã®ã§ããã
å®éäžã被èŠãã¹ã掻æ§æåã®ç²åã¯æ¥µããŠäžèŠ
åãªåœ¢ç¶ãæããå¯å¡å€ã®æ·»å ã«ãã埮现ãã€åº
äœã®è¢«èŠãã€ã«ã ãåŸãããšãã§ããããã¯æŽ»æ§
æåã®ç²åã®é ã ã«ååã«ä»çãããããšãã°ã
ãªã¢ã»ãã³åã¯ããªãªãã·ãšãã¬ã³ã°ãªã³ãŒã«
4000è¥ããã¯6000ã䜿çšããããšãã§ãããããš
ãã°ããªãªãã·ãšãã¬ã³ã°ã«ã³ãŒã«6000ã®ãããª
氎溶æ§å¯å¡å€ãæ··åç©ã«å¯ŸãçŽ0.2ãïŒééïŒ ã®
å²åã§äœ¿çšããã®ãç¹ã«å¥œé©ã§ããã
æ¬çºæã«ãããŠç¹ã«å¥œé©ãªè¬å€ã¯ã掻æ§æåã
ããããªãã«ãšãªã¹ããã€ã·ã³ã§ãã€ãŠããã®ã¿
ãã¬ããç¶ã®çµæ¶ãæ°ÎŒã100ÎŒã®ç¯å²ã®å¯žæ³ã
æãããã®ã§ãããããããªãããæ°Žæ§åªäœäžã§
å ç±ããããšã«ããããããçµæ¶ã¯çŽåŸçŽ3ÎŒã
ã€é·ãæ°ÎŒãçŽ100ÎŒã®éç¶ã®åœ¢æ ãšãªãã
ããããªãã«ãšãªã¹ããã€ã·ã³ã§ãã€ãŠããã®ã¿
ãã¬ããç¶ã®çµæ¶ãæ°ÎŒã100ÎŒã®ç¯å²ã®å¯žæ³ã
æãããã®ã§ãããããããªãããæ°Žæ§åªäœäžã§
å ç±ããããšã«ããããããçµæ¶ã¯çŽåŸçŽ3ÎŒã
ã€é·ãæ°ÎŒãçŽ100ÎŒã®éç¶ã®åœ¢æ ãšãªãã
ãããè¬å€ã®ãã¡ã奜ãŸããã¯åºäœçæ°Žæ§ç©è³ª
ãäžåŒã®äžæ§ã¢ã¯ãªã«æš¹èã§ããããšãç¹åŸŽãšã
ããã®ããããããïŒ ãåŒäžãã¯æ°ŽçŽ åååã¯ã¡ãã«åºã瀺ãã
Râ²ã¯ã¡ãã«è¥ããã¯ãšãã«åºã瀺ããïœã¯åèš
æš¹èãçŽ200000ã600000ã®ååéãæããã€ä¹Ÿç¥
ééãšããŠããããªãã«ãšãªã¹ããã€ã·ã³ã®éé
ã«å¯ŸãïŒã15ïŒ ãšãªããããªæ°ã§ãããã
ãäžåŒã®äžæ§ã¢ã¯ãªã«æš¹èã§ããããšãç¹åŸŽãšã
ããã®ããããããïŒ ãåŒäžãã¯æ°ŽçŽ åååã¯ã¡ãã«åºã瀺ãã
Râ²ã¯ã¡ãã«è¥ããã¯ãšãã«åºã瀺ããïœã¯åèš
æš¹èãçŽ200000ã600000ã®ååéãæããã€ä¹Ÿç¥
ééãšããŠããããªãã«ãšãªã¹ããã€ã·ã³ã®éé
ã«å¯ŸãïŒã15ïŒ ãšãªããããªæ°ã§ãããã
ããã«ãæ¬çºæã«ããè¬å€ã¯ãåŸãããæ°èŠãª
被èŠè¬å€ããããã®å«æããåãæªè¢«èŠæŽ»æ§æå
ãšåæ§ã«äœ¿çšããããªãã°ãäžèšãããã®ãšç°ãª
ãä»ã®çäœãšããŠäœ¿çšããããšãã§ããã
被èŠè¬å€ããããã®å«æããåãæªè¢«èŠæŽ»æ§æå
ãšåæ§ã«äœ¿çšããããªãã°ãäžèšãããã®ãšç°ãª
ãä»ã®çäœãšããŠäœ¿çšããããšãã§ããã
æåŸã«ãæ¬çºæã®äž»é¡ã¯ãå°ãªããšãäžçš®ã®äž
èšããè¬å€ãå«æããããšãç¹åŸŽãšããçµå£æäž
çšã®æ°èŠãªå»è¬çµæç©ã§ããã
èšããè¬å€ãå«æããããšãç¹åŸŽãšããçµå£æäž
çšã®æ°èŠãªå»è¬çµæç©ã§ããã
ãããã®å»è¬çµæç©ã¯ãããšãã°åºäœåã¯æ¶²äœ
ãšããããšãã§ããçŸåšäººéçšå»è¬ãšããŠäœ¿çšã
ããŠããçµå£æäžçšã®å»è¬åœ¢æ ãããšãã°ãã®ãŸ
ãŸã®åã¯ç³è¡£ãããå§æŸé ããŒã©ãã³ã«ãã»ã«æ
ãã¯é¡ç²ãšããŠã¯æäŸããããšãã§ãããããã
ã¯åžžæ³ã«ãã補é ãããã被èŠããã掻æ§æå
ãããããå»è¬çµæç©äžã«é垞䜿çšãããè£åœ¢
è¬ãããšãã°ã¿ã«ã¯ãã¢ã©ãã€ãŽã ãä¹³ç³ã殿
ç²ãã¹ãã¢ãªã³é žãã°ãã·ãŠã ãæ°Žæ§ããã¯ã«ã
åçš®ã®æ¹¿æœ€å€ãåæ£å€è¥ããã¯ä¹³åå€åã³ïŒå
ã¯ïŒä¿åæã®äžã«é åããããšãã§ããã
ãšããããšãã§ããçŸåšäººéçšå»è¬ãšããŠäœ¿çšã
ããŠããçµå£æäžçšã®å»è¬åœ¢æ ãããšãã°ãã®ãŸ
ãŸã®åã¯ç³è¡£ãããå§æŸé ããŒã©ãã³ã«ãã»ã«æ
ãã¯é¡ç²ãšããŠã¯æäŸããããšãã§ãããããã
ã¯åžžæ³ã«ãã補é ãããã被èŠããã掻æ§æå
ãããããå»è¬çµæç©äžã«é垞䜿çšãããè£åœ¢
è¬ãããšãã°ã¿ã«ã¯ãã¢ã©ãã€ãŽã ãä¹³ç³ã殿
ç²ãã¹ãã¢ãªã³é žãã°ãã·ãŠã ãæ°Žæ§ããã¯ã«ã
åçš®ã®æ¹¿æœ€å€ãåæ£å€è¥ããã¯ä¹³åå€åã³ïŒå
ã¯ïŒä¿åæã®äžã«é åããããšãã§ããã
以äžã®äŸã«ããæ¬çºæã説æãããããããã«
ããæ¬çºæã¯å¶éããããã®ã§ã¯ãªãã
ããæ¬çºæã¯å¶éããããã®ã§ã¯ãªãã
äŸ ïŒ
被èŠããããªãã«ãšãªã¹ããã€ã·ã³ã®è£œé
äºéå£ã®ã·ãããç
®ã€ãåšã«ã匷åãªæ¹æäž
ïŒ700rpmïŒã§æ¬¡ã®ãã®ãå ¥ããïŒ108ã®çŽæ°Žã
260ã®ãã«ãããã¯F68åã³390ïœã®ããªãªãã·
ãšãã¬ã³ã°ãªã³ãŒã«6000ãå šäœãå®å šã«æº¶è§£ãã
ãŸã§10åéæ¹æãã次ãã§13Kgã®éçé žãããªãŠ
ã ãå ããŠå šäœã30åéæ¹æãã3250Kgã®ãŠãŒã
ã©ã®ããE30Dã®æ°Žæ§åæ£ç©ïŒä¹Ÿç¥ã¯ãã¹975ïœã«
çžåœïŒãš13Kgã®890IUïŒmgã®ããããªãã«ãšãªã¹
ããã€ã·ã³ãšãå ãã次ãã§10ååŸã«æ¹æãç¶ã
ãªããçŽæ°Ž174mläž8.6ïœã®æ¶æ³¡çšã·ãªã³ãŒã³
oblNã®æžæ¿ç©ãå ãããå šäœãæ¹æäžã«45åé
æŸçœ®ãããã®èª¿è£œç©ãäºéåºäžã®æ°Žèžæ°ã«ããå
ç±ããŠïŒæéã«ããã55âã®æž©åºŠãšãªããæ¹æã
ç¶ããããã®æž©åºŠã15åéä¿ã¡ã次ãã§å ç±ãã
ãŠãªãçŽæ°Ž6.5äžã®å¡©åãããªãŠã 1.3Kgã®æº¶æ¶²
ãå ããŠå šäœãåã³55âã«ãŠ45åéæ¹æããæ··å
ç©ã10âã®æ°Žã®åŸªç°ã«ãã35åéå·åŽããŠ15ã20
âãšãªãããããŠããªãããã¬ã³ã¬ãŒãŒãåãã
ã€ããã¯ã¹è£œã®ããããŒã«ãŠæžå§äžã§åé¢ããã
åé¢ã±ãŒããçŽæ°Ž44ãçšããŠæ©æ¢°æ¹æäžã«10å
éãããŠããŒã¹ããšãªããåã³ããããŒã§é
ããæ°Ž21ã§æŽæµããåé¢ããããŠ50âã®ææ°ãª
ãŒãã³å ã§ä¹Ÿç¥ãããã20æéã®ä¹Ÿç¥åŸãçæç©
ãïŒmmã¡ãã·ãŠã®æ Œåãåããç²åºŠã»ã«ãéãã
åã³ææ°ãªãŒãã³å ã§ïŒæé也ç¥ããã次ãã§
400ÎŒã¡ãã·ãŠã®æ Œåãåããç²åºŠã»ã«ã«éãã
ããããŠ13.870Kgã®åŠçããããªãã«ãšãªã¹ãã
ã€ã·ã³ãåŸãããããã¯æž¬å®å€ã807IUïŒmgã§ã
ããã®å³ã¯é èœãããŠããã
ïŒ700rpmïŒã§æ¬¡ã®ãã®ãå ¥ããïŒ108ã®çŽæ°Žã
260ã®ãã«ãããã¯F68åã³390ïœã®ããªãªãã·
ãšãã¬ã³ã°ãªã³ãŒã«6000ãå šäœãå®å šã«æº¶è§£ãã
ãŸã§10åéæ¹æãã次ãã§13Kgã®éçé žãããªãŠ
ã ãå ããŠå šäœã30åéæ¹æãã3250Kgã®ãŠãŒã
ã©ã®ããE30Dã®æ°Žæ§åæ£ç©ïŒä¹Ÿç¥ã¯ãã¹975ïœã«
çžåœïŒãš13Kgã®890IUïŒmgã®ããããªãã«ãšãªã¹
ããã€ã·ã³ãšãå ãã次ãã§10ååŸã«æ¹æãç¶ã
ãªããçŽæ°Ž174mläž8.6ïœã®æ¶æ³¡çšã·ãªã³ãŒã³
oblNã®æžæ¿ç©ãå ãããå šäœãæ¹æäžã«45åé
æŸçœ®ãããã®èª¿è£œç©ãäºéåºäžã®æ°Žèžæ°ã«ããå
ç±ããŠïŒæéã«ããã55âã®æž©åºŠãšãªããæ¹æã
ç¶ããããã®æž©åºŠã15åéä¿ã¡ã次ãã§å ç±ãã
ãŠãªãçŽæ°Ž6.5äžã®å¡©åãããªãŠã 1.3Kgã®æº¶æ¶²
ãå ããŠå šäœãåã³55âã«ãŠ45åéæ¹æããæ··å
ç©ã10âã®æ°Žã®åŸªç°ã«ãã35åéå·åŽããŠ15ã20
âãšãªãããããŠããªãããã¬ã³ã¬ãŒãŒãåãã
ã€ããã¯ã¹è£œã®ããããŒã«ãŠæžå§äžã§åé¢ããã
åé¢ã±ãŒããçŽæ°Ž44ãçšããŠæ©æ¢°æ¹æäžã«10å
éãããŠããŒã¹ããšãªããåã³ããããŒã§é
ããæ°Ž21ã§æŽæµããåé¢ããããŠ50âã®ææ°ãª
ãŒãã³å ã§ä¹Ÿç¥ãããã20æéã®ä¹Ÿç¥åŸãçæç©
ãïŒmmã¡ãã·ãŠã®æ Œåãåããç²åºŠã»ã«ãéãã
åã³ææ°ãªãŒãã³å ã§ïŒæé也ç¥ããã次ãã§
400ÎŒã¡ãã·ãŠã®æ Œåãåããç²åºŠã»ã«ã«éãã
ããããŠ13.870Kgã®åŠçããããªãã«ãšãªã¹ãã
ã€ã·ã³ãåŸãããããã¯æž¬å®å€ã807IUïŒmgã§ã
ããã®å³ã¯é èœãããŠããã
äŸ ïŒ
被èŠããããªãã«ãšãªã¹ããã€ã·ã³ã®è£œé
842mlã®çŽæ°ŽãããŒã«ãŒäžã«å
¥ãã次ãã§æ¹æ
äžã«ïŒïœã®ããªãªãã·ãšãã¬ã³ã°ãªã³ãŒã«6000ãš
ïŒïœã®ãã«ãããã¯F68ãšãå ããŠå šäœãïŒåé
æ¹æãã次ãã§50ïœã®ãŠãŒãã©ã®ããL30Dãå
ããŠå šäœã10åéæ¹æãã次ãã§100ïœãããã
ãªãã«ãšãªã¹ããã€ã·ã³ãå ããŠå šäœã15åéæ¹
æãã次ãã§20åéãããŠ55âã«å ç±ããããŠã
ã®æž©åºŠã15åéç¶æããã次ãã§10ïœã®å¡©åãã
ãªãŠã ãå ããŠå šäœãåã³55âã§45åéå ç±ãã
次ãã§20âãŸã§å·åŽãã綿ã¬ãŒãŒãåããããã
ãŒã«ããéãããã®éã±ãŒãã500mlã®æ°Žã§
æŽæµããææ°ãªãŒãã³å ã§50âã«ãŠ16æé也ç¥ã
ãã400ÎŒã¡ãã·ãŠãåãã篩ã«éãããããŠå³
ãé èœãããã€æž¬å®å€ã732IUïŒmgã§ããåŠçã
ãããªãã«ãšãªã¹ããã€ã·ã³108.9ïœãåŸãããã
äžã«ïŒïœã®ããªãªãã·ãšãã¬ã³ã°ãªã³ãŒã«6000ãš
ïŒïœã®ãã«ãããã¯F68ãšãå ããŠå šäœãïŒåé
æ¹æãã次ãã§50ïœã®ãŠãŒãã©ã®ããL30Dãå
ããŠå šäœã10åéæ¹æãã次ãã§100ïœãããã
ãªãã«ãšãªã¹ããã€ã·ã³ãå ããŠå šäœã15åéæ¹
æãã次ãã§20åéãããŠ55âã«å ç±ããããŠã
ã®æž©åºŠã15åéç¶æããã次ãã§10ïœã®å¡©åãã
ãªãŠã ãå ããŠå šäœãåã³55âã§45åéå ç±ãã
次ãã§20âãŸã§å·åŽãã綿ã¬ãŒãŒãåããããã
ãŒã«ããéãããã®éã±ãŒãã500mlã®æ°Žã§
æŽæµããææ°ãªãŒãã³å ã§50âã«ãŠ16æé也ç¥ã
ãã400ÎŒã¡ãã·ãŠãåãã篩ã«éãããããŠå³
ãé èœãããã€æž¬å®å€ã732IUïŒmgã§ããåŠçã
ãããªãã«ãšãªã¹ããã€ã·ã³108.9ïœãåŸãããã
äŸ ïŒ
被èŠããããªãã«ãšãªã¹ããã€ã·ã³ã®å§æŸé ã®
補é äŸïŒã§åŸããã68.3ïœã®åŠçããããªãã«ãšãª
ã¹ããã€ã·ã³ãš21.4ïœã®ã¢ãã»ã«PH101ãš9.1ïœã®
ãšããããã殿ç²ãš1.6ïœã®ãµãã«ãªã³é žãããª
ãŠã ãšãæ··åãã次ãã§1.54ïœã®ãšããããã殿
ç²ãå«æãã50âã®ããŒã¹ã60ïœãå ¥ããŠå šäœã
50mlã§æŽæµãã1.6mmã¡ãã·ãŠã®ç¯©ã«ãã篩åãã
ææ°ãªãŒãã³å ã§50âã«ãŠïŒæé也ç¥ãããïŒmm
ã¡ãã·ãŠã®ã°ã©ããŠã¬ãŒã¿ãŒã«ãããããŠ100ïœ
ã®é¡æµãåŸããåŸãããé¡ç²ãïŒïœã®ãã«ããã
ã¹ã»ãã€ãããã«ïŒãªã¬ã³ãž10A77ã27.7ïœã®ã¢
ãã»ã«PH101ã8.3ïœã®æ®¿ç²åã³1.6ïœã®ãšã¢ãã·
ã«200ãš30åéæ··åãã1.2ïœã®ã¿ã«ã¯ãšïŒïœã®ã¹
ãã¢ãªã³é žãã°ãã·ãŠã ãšãå ããŠå šäœãåã³ïŒ
åéæ··åãã次ãã§å§æŸæ©ã«ãããã
補é äŸïŒã§åŸããã68.3ïœã®åŠçããããªãã«ãšãª
ã¹ããã€ã·ã³ãš21.4ïœã®ã¢ãã»ã«PH101ãš9.1ïœã®
ãšããããã殿ç²ãš1.6ïœã®ãµãã«ãªã³é žãããª
ãŠã ãšãæ··åãã次ãã§1.54ïœã®ãšããããã殿
ç²ãå«æãã50âã®ããŒã¹ã60ïœãå ¥ããŠå šäœã
50mlã§æŽæµãã1.6mmã¡ãã·ãŠã®ç¯©ã«ãã篩åãã
ææ°ãªãŒãã³å ã§50âã«ãŠïŒæé也ç¥ãããïŒmm
ã¡ãã·ãŠã®ã°ã©ããŠã¬ãŒã¿ãŒã«ãããããŠ100ïœ
ã®é¡æµãåŸããåŸãããé¡ç²ãïŒïœã®ãã«ããã
ã¹ã»ãã€ãããã«ïŒãªã¬ã³ãž10A77ã27.7ïœã®ã¢
ãã»ã«PH101ã8.3ïœã®æ®¿ç²åã³1.6ïœã®ãšã¢ãã·
ã«200ãš30åéæ··åãã1.2ïœã®ã¿ã«ã¯ãšïŒïœã®ã¹
ãã¢ãªã³é žãã°ãã·ãŠã ãšãå ããŠå šäœãåã³ïŒ
åéæ··åãã次ãã§å§æŸæ©ã«ãããã
6.6ã7.2Kgã®ç¡¬ãã®å§æŸé ãåŸã23âã®æ°Žäžã§
20ã25ç§é厩å£ããããæžæ¿ç©ã®å³ã¯å šãè¯å¥œã§
ããã倧ããŠçå³ããªãã€ãã
20ã25ç§é厩å£ããããæžæ¿ç©ã®å³ã¯å šãè¯å¥œã§
ããã倧ããŠçå³ããªãã€ãã
äŸ ïŒ
被èŠããããªãã«ãšãªã¹ããã€ã·ã³ã®å§æŸé ã®
補é äŸïŒã«èšèŒããæé ãšåãæé ãçšããŠå§æŸé
ã補é ãããããããªæ¬¡ã®çµæã«çžåœããïŒ äŸïŒã§åŸãããåŠçããããªãã«ãšãªã¹ããã€ã·
ã³ âŠâŠ310mg ãšã¢ãã·ã«200 âŠâŠïŒmg ãšãããããæ®¿ç² âŠâŠ90mg ãã«ãããã¹ã»ãã€ãããã«ïŒãªã¬ã³ãž10A77
âŠâŠ35mg ãµãã«ãªã³é žãããªãŠã âŠâŠïŒmg ã¹ãã¢ãªã³é žãã°ãã·ãŠã âŠâŠïŒmg ã¿ã«ã¯ âŠâŠïŒmg å³éã®å§æŸé ïŒåã«ããã®ã«èŠããã¢ãã»ã«PH
101 âŠâŠ740mg å§æŸé ã«ãããŠç¡¬ãïŒã8.6Kgã§ãããçŽ35ã
46ç§éã§åŽ©å£ããã
補é äŸïŒã«èšèŒããæé ãšåãæé ãçšããŠå§æŸé
ã補é ãããããããªæ¬¡ã®çµæã«çžåœããïŒ äŸïŒã§åŸãããåŠçããããªãã«ãšãªã¹ããã€ã·
ã³ âŠâŠ310mg ãšã¢ãã·ã«200 âŠâŠïŒmg ãšãããããæ®¿ç² âŠâŠ90mg ãã«ãããã¹ã»ãã€ãããã«ïŒãªã¬ã³ãž10A77
âŠâŠ35mg ãµãã«ãªã³é žãããªãŠã âŠâŠïŒmg ã¹ãã¢ãªã³é žãã°ãã·ãŠã âŠâŠïŒmg ã¿ã«ã¯ âŠâŠïŒmg å³éã®å§æŸé ïŒåã«ããã®ã«èŠããã¢ãã»ã«PH
101 âŠâŠ740mg å§æŸé ã«ãããŠç¡¬ãïŒã8.6Kgã§ãããçŽ35ã
46ç§éã§åŽ©å£ããã
äŸ ïŒ
被èŠãããã«ãªãã«ãšãªã¹ããã€ã·ã³ã®è£œé
0.75ïœã®ããªãªãã·ãšãã¬ã³ã°ãªã³ãŒã«6000ãš
ïŒïœã®ãã«ãããã¯F68ãšãæ°Ž600mläžã«æº¶è§£ã
ãã6.25ïœã®ãŠãŒãã©ã®ããE30Dãå ¥ãã100ïœ
ã®ããããªãã«ãšãªã¹ããã€ã·ã³ãå ããŠå šäœã
ã15åéæ¹æãã枩床ãæ¹æäžã«55âãšãªããã
ã®æž©åºŠãïŒæéä¿ã¡ãã®çµäºæã«ïŒåéãããŠæ°Ž
50mläžã®å¡©åãããªãŠã 10ïœã®æº¶æ¶²ãå ããå šäœ
ã20ã22âã«å·åŽããæ¹æäžã«ïŒæéä¿ã¡ããã
ããŒã§éããæ°Ž500mlã§æŽæµããããŠææ°ãªãŒ
ãã³å ã§50âã«ãŠ12æé也ç¥ããããã®ä¹Ÿç¥ãã
çæç©ã400ÎŒã¡ãã·ãŠã®ç¯©ã«éããããããŠèŠ
å³ã®äž»èŠéšåãé èœããã被èŠããããªãã«ãšãª
ã¹ããã€ã·ã³99ïœãåŸãããã
ïŒïœã®ãã«ãããã¯F68ãšãæ°Ž600mläžã«æº¶è§£ã
ãã6.25ïœã®ãŠãŒãã©ã®ããE30Dãå ¥ãã100ïœ
ã®ããããªãã«ãšãªã¹ããã€ã·ã³ãå ããŠå šäœã
ã15åéæ¹æãã枩床ãæ¹æäžã«55âãšãªããã
ã®æž©åºŠãïŒæéä¿ã¡ãã®çµäºæã«ïŒåéãããŠæ°Ž
50mläžã®å¡©åãããªãŠã 10ïœã®æº¶æ¶²ãå ããå šäœ
ã20ã22âã«å·åŽããæ¹æäžã«ïŒæéä¿ã¡ããã
ããŒã§éããæ°Ž500mlã§æŽæµããããŠææ°ãªãŒ
ãã³å ã§50âã«ãŠ12æé也ç¥ããããã®ä¹Ÿç¥ãã
çæç©ã400ÎŒã¡ãã·ãŠã®ç¯©ã«éããããããŠèŠ
å³ã®äž»èŠéšåãé èœããã被èŠããããªãã«ãšãª
ã¹ããã€ã·ã³99ïœãåŸãããã
äŸ ïŒ
被èŠããããªãã«ãšãªã¹ããã€ã·ã³ã®è£œé
7.2ã®æ°Žãš240ïœã®ããªãªãã·ãšãã¬ã³ã°ãªã³
ãŒã«6000ãš20ïœã®ãã«ãããã¯F68ãšãæ··åããŠ
ïŒåéæ¹æããïŒKgã®ãŠãŒãã©ã®ããE30Dãå
ããŠå šäœã0.8ã®æ°Žã§æŽæµããããããïŒåé
æ¹æããïŒKgã®ããããªãã«ãšãªã¹ããã€ã·ã³ã
å ããŠå šäœã30åéæ¹æãã75âã«ãŠ80åéå ç±
ãããã®æž©åºŠã15åéä¿ã¡ãããã«æ¹æäžã«å šäœ
ãåšå²æž©åºŠãŸã§å·åŽããåã³ïŒæéæ¹æããŠãã
ããŒã«ããæžå§äžã§éãã4.5ã®æ°Žãšå ±ã«30
åéæ¹æããŠããŒã¹ããšãªããåé¢ããïŒã®æ°Ž
ã§æŽæµããïŒæéåé¢ãããç²ç¶åãããææ°ãª
ãŒãã³å ã§50âã«ãŠ12æé也ç¥ãããããŠ800ÎŒ
ã¡ãã·ãŠæ¬¡ãã§400ÎŒã¡ãã·ãŠã®ç¯©ã«éããŠäºæ
ããçç£ç©1.513KgãåŸãã
ãŒã«6000ãš20ïœã®ãã«ãããã¯F68ãšãæ··åããŠ
ïŒåéæ¹æããïŒKgã®ãŠãŒãã©ã®ããE30Dãå
ããŠå šäœã0.8ã®æ°Žã§æŽæµããããããïŒåé
æ¹æããïŒKgã®ããããªãã«ãšãªã¹ããã€ã·ã³ã
å ããŠå šäœã30åéæ¹æãã75âã«ãŠ80åéå ç±
ãããã®æž©åºŠã15åéä¿ã¡ãããã«æ¹æäžã«å šäœ
ãåšå²æž©åºŠãŸã§å·åŽããåã³ïŒæéæ¹æããŠãã
ããŒã«ããæžå§äžã§éãã4.5ã®æ°Žãšå ±ã«30
åéæ¹æããŠããŒã¹ããšãªããåé¢ããïŒã®æ°Ž
ã§æŽæµããïŒæéåé¢ãããç²ç¶åãããææ°ãª
ãŒãã³å ã§50âã«ãŠ12æé也ç¥ãããããŠ800ÎŒ
ã¡ãã·ãŠæ¬¡ãã§400ÎŒã¡ãã·ãŠã®ç¯©ã«éããŠäºæ
ããçç£ç©1.513KgãåŸãã
äŸ ïŒ
被èŠããããªãã«ãšãªã¹ããã€ã·ã³ã®å§æŸé ã®
補é çŽæ¥å§æŸã«ããïŒïœã®å§æŸé ã補é ããããã¯
次ã®çµæã«çžåœããïŒ äŸïŒã®ããããªãã«ãšãªã¹ããã€ã·ã³ âŠâŠ457mg ã¢ãã»ã«PH101 âŠâŠ19.65mg ãšã¢ãã·ã«200 âŠâŠ15mg ãšãããããæ®¿ç² âŠâŠ90mg ããªããŸãç² âŠâŠ222mg ã¡ã³ããŒã« âŠâŠ0.5mg å¯æº¶æ§ã³ã³ã¢ âŠâŠ10mg ãµãã«ãªã³é žãããªãŠã âŠïŒmg ã¿ã«ã âŠâŠïŒmg ã¹ãã¢ãªã³é žãã°ãã·ãŠã âŠâŠïŒmg åŸãããå§æŸç¶ã¯16ã20Kgã®ç¡¬ããæããåšå²
枩床ã«ãŠæ°Žäžã«45ã75ç§éã§åŽ©å£ããã
補é çŽæ¥å§æŸã«ããïŒïœã®å§æŸé ã補é ããããã¯
次ã®çµæã«çžåœããïŒ äŸïŒã®ããããªãã«ãšãªã¹ããã€ã·ã³ âŠâŠ457mg ã¢ãã»ã«PH101 âŠâŠ19.65mg ãšã¢ãã·ã«200 âŠâŠ15mg ãšãããããæ®¿ç² âŠâŠ90mg ããªããŸãç² âŠâŠ222mg ã¡ã³ããŒã« âŠâŠ0.5mg å¯æº¶æ§ã³ã³ã¢ âŠâŠ10mg ãµãã«ãªã³é žãããªãŠã âŠïŒmg ã¿ã«ã âŠâŠïŒmg ã¹ãã¢ãªã³é žãã°ãã·ãŠã âŠâŠïŒmg åŸãããå§æŸç¶ã¯16ã20Kgã®ç¡¬ããæããåšå²
枩床ã«ãŠæ°Žäžã«45ã75ç§éã§åŽ©å£ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ å€§ããŠæ°Žæº¶æ§ã§ãªã埮ç²å圢æ ã®åºäœç¶å»è¬
掻æ§æåã§ããããããªãã«ãšãªã¹ããã€ã·ã³ã
被èŠããæ¹æ³ã«ãããŠã該ããããªãã«ãšãªã¹ã
ãã€ã·ã³ãšå»è¬äžèš±å®¹ãããåºäœçæ°Žæ§ç©è³ªã§ã
ãæ¬¡åŒ ïŒ»åŒäžãã¯æ°ŽçŽ åååã¯ã¡ãã«åºã瀺ãã
Râ²ã¯ã¡ãã«åã¯ãšãã«åºã瀺ããïœã¯åèšæš¹è
ãçŽ200000ã600000ã®ååéãæãããããªæ°ã§
ãã ã®äžæ§ã¢ã¯ãªã«æš¹èã®æ°Žæ§åæ£ç©ãšãã¢ã¯ãªã«æš¹
èïŒéšã«å¯ŸãçŽïŒã60éšã®ããããªãã«ãšãªã¹ã
ãã€ã·ã³ã®å²åã§æªæäžã«æ··åããå°ãªããšãäž
çš®ã®ç©ççè¥ããã¯ååŠçæ段åã¯ãããæ段ã®
çµåãã䜿çšããŠåèšçæ°Žæ§ç©è³ªãåéãããã
ã®ããã«ããŠè¢«èŠããã掻æ§æåãåé¢ããŠä¹Ÿç¥
ããããšãç¹åŸŽãšãããåºäœããããªãã«ãšãªã¹
ããã€ã·ã³ã被èŠããæ¹æ³ã ïŒ äœ¿çšããåéã®ç©ççæ段ã枩床ã®å€åã§ã
ãããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®
æ¹æ³ã ïŒ äœ¿çšããååŠçåéæ段ãé»è§£è³ªã§ããããš
ãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒåã¯ïŒé èšèŒã®
æ¹æ³ã ïŒ é»è§£è³ªãå¡©åãããªãŠã ã§ããããšãç¹åŸŽãš
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ æ··åæäœã®éããã«æ¹¿æœ€å€ãå ããããšãç¹
城ãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ æ··åæäœã®éããã«å¯å¡å€ãå ããããšãç¹
城ãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ æ··åæäœã®éããã«æ¶èå€ãå ããããšãç¹
城ãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ æ··åæäœã®éããã«å°ãªããšãäžçš®ã®æ°Žæº¶æ§
åã¯èŠªæ°Žæ§æ·»å ç©ãé åããããšãç¹åŸŽãšããç¹
èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒ æ··åç©ãïŒéšã®ã¢ã¯ãªã«æš¹èã«å¯ŸããŠçŽïŒã
15éšã®ããããªãã«ãšãªã¹ããã€ã·ã³ã§ãã掻æ§
æåãšïŒã15éšã®éçé žãããªãŠã ã§ãã氎溶æ§
è¥ããã¯èŠªæ°Žæ§æ·»å ç©ãšãå«æããããšãç¹åŸŽãš
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®æ¹æ³ã ïŒïŒ 倧ããŠæ°Žæº¶æ§ã§ãªã埮ç²å圢æ ã®åºäœç¶å»
è¬æŽ»æ§æåã§ããããããªãã«ãšãªã¹ããã€ã·ã³
ã«ããæ§æãããåèšæŽ»æ§æåãå»è¬äžèš±å®¹ãã
ãåºäœç¶çæ°Žæ§ç©è³ªã§ããæ¬¡åŒ ïŒ»åŒäžãã¯æ°ŽçŽ åååã¯ã¡ãã«åºã瀺ãã
Râ²ã¯ã¡ãã«åã¯ãšãã«åºã瀺ããïœã¯åèšæš¹è
ãçŽ200000ã600000ã®ååéãæãããããªæ°ã§
ãã ã®äžæ§ã¢ã¯ãªã«æš¹èã®æ°Žæ§åæ£ç©ã®åéã«ãã圢
æããã被èŠã§èŠãããŠããããšãç¹åŸŽãšããæ°
èŠè¬å€ã ïŒïŒ 被èŠãããã«å°ãªããšãäžçš®ã®æ°Žæº¶æ§åã¯
芪氎æ§æ·»å ç©ãå«æããããšãç¹åŸŽãšããç¹èš±è«
æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®è¬å€ã ïŒïŒ 氎溶æ§åã¯èŠªæ°Žæ§æ·»å ç©ãéçé žãããªãŠ
ã åã³å¡©åãããªãŠã ãããªã矀ããéžæããã
ããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒé èšèŒã®
è¬å€ã ïŒïŒ 被èŠãããã«å¯å¡å€ãå«æããããšãç¹åŸŽ
ãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒãïŒïŒé ã®ãããã
ã«èšèŒã®è¬å€ã ïŒïŒ æš¹èã®ä¹Ÿç¥ééã掻æ§æåã®ééã®ïŒã15
ïŒ ã§ããããšãç¹åŸŽãšããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒïŒ
é èšèŒã®è¬å€ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8004199A FR2476485A1 (fr) | 1980-02-26 | 1980-02-26 | Nouveau procede d'enrobage d'au moins un principe actif medicamenteux, les nouveaux medicaments ainsi obtenus, et les compositions les renfermant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS56133214A JPS56133214A (en) | 1981-10-19 |
| JPH0530805B2 true JPH0530805B2 (ja) | 1993-05-11 |
Family
ID=9238982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2621481A Granted JPS56133214A (en) | 1980-02-26 | 1981-02-26 | Novel method of coating at least one kind of medicinally active component, novel drug obtained thereby and composition containing same |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0036345B1 (ja) |
| JP (1) | JPS56133214A (ja) |
| AT (1) | ATE4957T1 (ja) |
| CA (1) | CA1163923A (ja) |
| DE (1) | DE3161148D1 (ja) |
| DZ (1) | DZ270A1 (ja) |
| FR (1) | FR2476485A1 (ja) |
| MA (1) | MA19084A1 (ja) |
| OA (1) | OA06747A (ja) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4912146A (en) * | 1985-01-30 | 1990-03-27 | Warner-Lambert Company | Coated dosage forms |
| US4971791A (en) * | 1985-08-26 | 1990-11-20 | The Procter & Gamble Company | Taste masking compositions |
| US4874613A (en) * | 1987-03-06 | 1989-10-17 | Baker Cummins Pharmaceuticals, Inc. | Taste concealing pharmaceutical dosage unit |
| DE4328069A1 (de) * | 1993-08-20 | 1995-02-23 | Henning Berlin Gmbh | Mikropartikel, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln |
| ITPD20070274A1 (it) * | 2007-08-08 | 2009-02-09 | Sanypet S P A | Crocchetta per animali e metodo per la sua produzione |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2010110A1 (de) * | 1970-03-04 | 1971-09-16 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von Mikrokapseln mit Hilfe von synthetischen Koazervaten |
| US3922379A (en) * | 1973-12-17 | 1975-11-25 | Abbott Lab | Microencapsulation process |
| LU72439A1 (ja) * | 1975-05-09 | 1977-02-09 | ||
| JPS5394274A (en) * | 1977-01-29 | 1978-08-18 | Ricoh Co Ltd | Micro-encapsulating method |
-
1980
- 1980-02-26 FR FR8004199A patent/FR2476485A1/fr active Granted
-
1981
- 1981-02-17 OA OA57330A patent/OA06747A/xx unknown
- 1981-02-20 AT AT81400274T patent/ATE4957T1/de not_active IP Right Cessation
- 1981-02-20 DE DE8181400274T patent/DE3161148D1/de not_active Expired
- 1981-02-20 EP EP81400274A patent/EP0036345B1/fr not_active Expired
- 1981-02-25 CA CA000371719A patent/CA1163923A/fr not_active Expired
- 1981-02-25 DZ DZ816110A patent/DZ270A1/fr active
- 1981-02-25 MA MA19288A patent/MA19084A1/fr unknown
- 1981-02-26 JP JP2621481A patent/JPS56133214A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| CA1163923A (fr) | 1984-03-20 |
| DZ270A1 (fr) | 2004-09-13 |
| OA06747A (fr) | 1982-06-30 |
| DE3161148D1 (en) | 1983-11-17 |
| MA19084A1 (fr) | 1981-10-01 |
| EP0036345A1 (fr) | 1981-09-23 |
| FR2476485A1 (fr) | 1981-08-28 |
| JPS56133214A (en) | 1981-10-19 |
| FR2476485B1 (ja) | 1983-03-04 |
| ATE4957T1 (de) | 1983-10-15 |
| EP0036345B1 (fr) | 1983-10-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100209175B1 (ko) | ìì€ìì ì ìíê² ííëë ìœì íì ì¡°ì±ë¬Œ | |
| KR900000212B1 (ko) | ìŠì ê· ì§ë§ìŽí¬ë¡ ìº ì ííì¡ì ì ì¡°ë°©ë² | |
| AU626031B2 (en) | New solid porous unitary form comprising micro-particles and/or nano-particles, and its preparation | |
| US4900557A (en) | Pellet formulation | |
| JP4129995B2 (ja) | æ°Žæ§åªäœã«è¿ éã«æžæ¿ããå»è¬çµæç© | |
| DE69832731T2 (de) | Arzneimittel mit magensaftresistentem ÃŒberzug und methode zur herstellung | |
| JPS6229514A (ja) | å»è¬æŽ»æ§ç©è³ªã®é 延æŸåºåœ¢ç²ç¶ç©åã³ãã®è£œé æ¹æ³ | |
| DE10254412A1 (de) | Arzneimittel | |
| JP2000500477A (ja) | å³ææŸåºåã®è¬åŠççµæç© | |
| US20020076444A1 (en) | Novel method for obtaining microspheres and resulting products | |
| JP4357422B2 (ja) | 匷åå³èŠãã¹ãã³ã°èœããã³é«æº¶åºé床ãæãããã€ã¯ãã«ãã»ã«è£œå€ã®è£œé æ¹æ³ | |
| JPH082781B2 (ja) | äžç©ºé¡ç²ç¶å»è¬åã³ãã®è£œæ³ | |
| JPH0530805B2 (ja) | ||
| RU2113851C1 (ru) | СПЎеÑжаМОе ЎОЌеÑОкПМ паÑÑОлкО О ÑпПÑПб ÐžÑ ÐžÐ·Ð³ÐŸÑÐŸÐ²Ð»ÐµÐœÐžÑ | |
| US5403594A (en) | Oral spiramycin formulations and method for preparing same | |
| US6555137B1 (en) | Sucralfate-containing composition and process for the preparation thereof | |
| WO1995005806A1 (en) | Microparticles, processes for their preparation and their use for the preparation of medicaments | |
| HU221435B (en) | Pellet-based pharmaceutical composition of controlled release with high content of potassium-chloride, and process for it's production | |
| RU2814336C1 (ru) | ÐÑÑÐŸÐºÐŸÐŽÐŸÐ·ÐœÐ°Ñ ÐºÐŸÐŒÐ¿ÐŸÐ·ÐžÑÐžÑ ÑÑаМекÑаЌПвПй кОÑлПÑÑ Ðž ÑпПÑÐŸÐ±Ñ ÐµÐµ пПлÑÑÐµÐœÐžÑ | |
| JP2553434B2 (ja) | ç²ç¶è£œå€ | |
| JPS587609B2 (ja) | ç²äœè¬å€ã®ã³âãã³ã°æ³ | |
| JPH0344319A (ja) | éæŸåºæå¶åå¶é žå€ | |
| HU201670B (en) | Process for producing compositions with controlled release of active ingredient, comprising inorganic or organic salts of pharmaceutically important cations as active ingredient | |
| HU191102B (en) | Process for producing pharmaceutical compositions of regulated dissolution of the active agents containing water-soluble inorganic pharmacons | |
| EP1051969A1 (en) | Coated antibiotic granules |